Provided by Tiger Trade Technology Pte. Ltd.

CytomX Therapeutics

3.28
-0.0100-0.30%
Post-market: 3.280.00000.00%19:30 EDT
Volume:2.89M
Turnover:9.61M
Market Cap:714.07M
PE:-7.21
High:3.42
Open:3.31
Low:3.27
Close:3.29
52wk High:8.21
52wk Low:1.90
Shares:217.70M
Float Shares:180.00M
Volume Ratio:1.08
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4548
EPS(LYR):-0.1500
ROE:-37.75%
ROA:-19.58%
PB:2.36
PE(LYR):-21.87

Loading ...

CytomX publishes corporate presentation on PROBODY platform oncology pipeline advances

Reuters
·
May 08

CytomX Therapeutics reports Q1 EPS (10c), consensus (11c)

TIPRANKS
·
May 08

CytomX Q1 revenue falls but beats analyst expectations

Reuters
·
May 08

CytomX Therapeutics Q1 EPS $(0.10) Beats $(0.20) Estimate, Sales $10.258M Beat $4.713M Estimate

Benzinga Earnings
·
May 08

CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 08

CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026

GlobeNewswire
·
Apr 30

CytomX Therapeutics announces annual shareholder meeting

Reuters
·
Apr 21

CytomX Therapeutics participates in a conference call with JPMorgan

TIPRANKS
·
Apr 13

CytomX Therapeutics Signals Progress in Varseta-M Trial

TIPRANKS
·
Apr 02

CytomX Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Mar 24

CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler

TIPRANKS
·
Mar 23

CytomX Therapeutics Raises $234 Million in Equity Offering

TIPRANKS
·
Mar 20

CytomX Therapeutics Is Maintained at Overweight by Barclays

Dow Jones
·
Mar 19

CytomX Therapeutics price target raised to $16 from $10 at Barclays

TIPRANKS
·
Mar 19

U.S. RESEARCH ROUNDUP-Carnival, Five Below, McKesson

Reuters
·
Mar 19

BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies

Reuters
·
Mar 19

Why Is CytomX Therapeutics Stock Falling On Wednesday?

Benzinga_recent_news
·
Mar 19

CytomX Therapeutics price target raised to $16 from $8 at Jefferies

TIPRANKS
·
Mar 18

CytomX Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 18

BUZZ-CytomX drops on $250 mln equity raise

Reuters
·
Mar 18